Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors
2024 · Cell Reports Medicine · 25 citations
https://doi.org/10.1016/j.xcrm.2023.101380
F
Francisco M. Bianchetto-Aguilera
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
648
Citations
12
h-index
13
i10-index
Francisco M. Bianchetto-Aguilera is an academic researcher from University of Verona. The author has contributed to research in topics: Immune cells in cancer & Immune Cell Function and Interaction & Chemokine receptors and signaling. The author has an h-index of 12, co-authored 40 publications.
ORCID: 0000-0003-3910-4715Papers by this author
worksNeutrophils restricted contribution of CCRL2 genetic variants to COVID-19 severity
2024 · Heliyon · 2 citations
https://doi.org/10.1016/j.heliyon.2024.e41267
Supplementary Table 1 from CCRL2 expression by specialized lung capillary endothelial cells controls NK-cell homing in lung cancer
2024 · 0 citations
https://doi.org/10.1158/2326-6066.27026762.v1
Supplementary Table 2 from CCRL2 expression by specialized lung capillary endothelial cells controls NK-cell homing in lung cancer
2024 · 0 citations
https://doi.org/10.1158/2326-6066.27026759.v1
Supplementary Figures from CCRL2 expression by specialized lung capillary endothelial cells controls NK-cell homing in lung cancer
2024 · 0 citations
https://doi.org/10.1158/2326-6066.27026765.v1
Data from CCRL2 expression by specialized lung capillary endothelial cells controls NK-cell homing in lung cancer
2024 · 0 citations
https://doi.org/10.1158/2326-6066.c.6758670.v3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat